Cresilon
NY - BrooklynBiotechnology
Focus: Cresilon is a Brooklyn-based biotech company focused on hemostatic gel technology, targeting ophthalmology and neurology indications. Limited public disclosure on company scale and stage.
Profile data last refreshed 20h ago · AI intelligence enriched 3w ago
Open Jobs
7-1 this month
Stable — net -1 jobs in 30d
1 added, 2 removed. Backfill posture.
Should You Work at Cresilon?
AI assessmentCresilon is a early-stage, innovation-focused play best suited for risk-tolerant scientists seeking deep technical involvement in a novel hemostatic platform; financial and pipeline opacity demands due diligence.
Why Work Here
- Early-stage biotech with focused R&D footprint (4 of 7 active roles in R&D) suggests hands-on innovation opportunity in hemostasis.
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
0 total
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Cresilon
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.